Objectives: To systematically evaluate auditory perceptual voice characteristics in people with thyroid disease prior to undergoing thyroid surgery. Patients and Methods: This study examined the auditory perceptual voice characteristics of 96 individuals with thyroid disease. Participants were categorised by type of thyroid disease (i.e. multinodular goitre, thyroid cancer, thyroid nodule, toxicity or parathyroidism) and by status of compression (i.e. compression versus no compression). Auditory perceptual voice ratings were made on samples of connected speech by using the Perceptual Voice Profile. Results: A high prevalence of participants had deviant auditory perceptual voice features; however, the majority of these abnormalities were slight to mild in severity and only 8% of participants had a clinically significant auditory perceptual abnormality. There was no significant difference in features between diagnostic categories, and only high pitch was rated as more significantly deviant in patients without compression versus those with compression. Conclusions: This study supports the need for auditory-perceptual ratings to be included as part of pre-operative multidimensional assessment of voice in patients with thyroid disease.

1.
Hong KH, Kim YK: Phonatory characteristics of patients undergoing thyroidectomy without laryngeal nerve injury. Otolaryngol Head Neck Surg 1997;117:399–404.
2.
Stemple JC, Glaze LE, Gerdeman Klaben BK: Clinical Voice Pathology: Theory and Management, ed 3.San Diego, Singular Publishing Group, 2000.
3.
Soylu L, Ozbas S, Uslu HY, Kocak S: The evaluation of the causes of subjective voice disturbances after thyroid surgery. Am J Surg 2007;194:317–322.
4.
Birkent H, Karacalioglu O, Merati AL, Akcam T, Gerek M: Prospective study of the impact of thyroid hormone replacement on objective voice parameters. Ann Otol Rhinol Laryngol 2008;117:523–527.
5.
Timon CI, Hirani SP, Epstein R, Rafferty MA: Investigation of the impact of thyroid surgery on vocal tract steadiness. J Voice 2010;24:610–613.
6.
Sataloff RT, Emerich, KA, Hoover CA: Endocrine dysfunction; in Satloff R (ed): Professional Voice: The Science and Art of Clinical Care, ed 2. San Diego, Singular Publishing, 1997.
7.
Kark AE, Kissin MW, Auerbach R, Neikle M: Voice changes after thyroidectomy: role of the external laryngeal nerve. BMJ 1984;289:1412–1415.
8.
McIvor NP, Flint DJ, Gillibrand J, Morton RP: Thyroid surgery and voice-related outcomes. Aust NZ J Surg 2000;70:179–183.
9.
Meek P, Carding N, Howard DH, Lennard TW: Voice change following thyroid and parathyroid surgery. J Voice 2008;22:765–772.
10.
Bicknell PG: Mild hypothyroidism and its effect on the larynx. J Laryngol Otol 1973;87:123–127.
11.
de Pedro Netto I, Fae A, Vartanian JG, Barros APB, Correia LM, Toledo RN, Testa JRG, Nishimoto IN, Kowalksi LP, Carrara-de Angelis E: Voice and vocal self-assessment after thyroidectomy. Head Neck 2006;28:1106–1114.
12.
Henry LR, Helou LB, Solomon NP, Howard RS, Gurevich-Uvena J, Coppit G, Stojadinovic A: Functional voice outcomes after thyroidectomy: an assessment of the Dysphonia Severity Index (DSI) after thyroidectomy. Surgery 2010;147:861–870.
13.
Stojadinovic A, Henry LR, Howard RS, Gurevich-Uvena J, Makashay MJ, Coppit GL, Shriver CD, Solomon N: Prospective trial of voice outcomes after thyroidectomy: evaluation of patient-reported and clinician-determined voice assessments in identifying postthyroidectomy dysphonia. Surgery 2008;143:732–742.
14.
Ortega J, Cassinello N, Dorcaratto D, Leopaldi E: Computerized acoustic voice analysis and subjective scaled evaluation of the voice can avoid the need for laryngoscopy after thyroid surgery. Surgery 2009;145:265–271.
15.
Aronson AE, Bless DM: Clinical Voice Disorders, ed 4. New York, Thieme, 2009.
16.
Carding P, Carlson E, Epstein R, Mathieson L, Shewell C: Formal perceptual evaluation of voice quality in the United Kingdom. Logoped Phoniatr Vocol 2000;25:133–138.
17.
Yu P, Revis J, Wuyts FL, Zanaret M, Giovanni A: Correlation of instrumental voice evaluation with perceptual voice analysis using a modified visual analog scale. Folia Phoniatr Logop 2002;54:271–281.
18.
Kempster GB, Gerratt BR, Verdolini Abbott K, Barkmeier-Kraemer J, Hillman RE: Consensus auditory-perceptual evaluation of voice: development of a standardized clinical protocol. Am J Speech Lang Pathol 2009;18:124–132.
19.
Darley F, Aronson A, Brown J: Motor Speech Disorders. Philadelphia, Saunders, 1975.
20.
Oates J, Russell A: Learning voice analysis using an interactive multi-media package: development and preliminary evaluation. J Voice 1998;12:500–512.
21.
Roh, JL, Yoon YH, Park CI: Recurrent laryngeal nerve paralysis in patients with papillary thyroid carcinomas: evaluation and management of resulting vocal dysfunction. Am J Surg 2009;197:459–465.
22.
Vertigan AE, Theodoros DG, Winkworth AL, Gibson PG: Perceptual voice characteristics in chronic cough and paradoxical vocal fold movement. Folia Phoniatr Logop 2007;59:256–267.
23.
Bele IV: Reliability in perceptual analysis of voice quality. J Voice2005;19:555–573.
24.
Critcher CR, Pannbacker M: Clinical evaluation of voice: noninstrumental. Curr Opin Otolaryngol Head Neck Surg 2000;8:153–157.
25.
Solomon NP, Helou LB, Stojadinovic A: Clinical versus laboratory ratings of voice using the CAPE-V. J Voice 2011;25:e7–e14.
26.
Bone SL, Vertigan AE, Eisenberg RE: Pre-operative assessment of voice abnormalities in patients with thyroid disease: a clinical data-mining exploration of ‘thyroid voice’; in Giles R, Epstein I, Vertigan A (eds): Clinical Data Mining in an Allied Health Organisation: A Real World Experience. Sydney, Sydney University Press, 2011, chap 9.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.